Qin Zhou

12PUBLICATIONS
103CO-AUTHORS
Predictive and prognostic markersForensic epidemiologyMolecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 25, 2026
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.

Maria M Rubinstein, Jennifer Y Ge, Qin Zhou

|Jan 29, 2026
Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset Cases.

Judy J Wang, Juliet Milani, Sarah Kane

|May 06, 2025
Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation.

M Herman Chui, Eun-Young Kang, Ryan M Kahn

|Nov 19, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer.

Angela K Green, Qin Zhou, Alexia Iasonos

|Sep 22, 2023
Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer.

Tiffany Y Sia, Anna Maio, Yelena M Kemel

|Aug 29, 2023
Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.

Claire F Friedman, Vignesh Ravichandran, Kathryn Miller

Pageof 2